Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: HIV-1 U3 tag virus integration sites in HEK293T

PROVIDER: PRJNA552541 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR9640929_1.fastq.gz	Fastqsanger.gz
	SRR9640929_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

HIV-1 integration sites in the absence of host factors SET2D and MLL1.

Project description:HIV-1 integration sites were determined in wild-type HEK293T cells and cells lacking SET2D or MLL1. These experiments were performed to test the role of SET2D and MLL1 in LEDGF/p75-dependent HIV-1 integration site selection. Integration libraries were prepared by ligation-mediated PCR and sequenced on Illumina NextSeq 2000 for 150 bp paired-end sequencing.

2026-02-25 | GSE279615 | GEO

Human immunodeficiency virus-1 targets genomic R-loops of the host for integration [RNA-seq]

Project description:Although HIV-1 integration sites are considered to favor active transcription units in the human genome, high-resolution analysis of individual HIV-1 integration sites have shown that the virus can integrate in a variety of host genomic locations, including non-genic regions, challenging the traditional understanding of HIV-1 integration site selection. Here, we showed that HIV-1 targets R-loops, a genomic structure made up of DNA–RNA hybrids, for integration. HIV-1 initiates the formation of R-loops in both genic and non-genic regions of the host genome and preferentially integrates into regions of HIV-1-induced R-loops. Using a cell model that can independently control transcriptional activity and R-loop formation, we demonstrated that the presence of R-loops, regardless of transcriptional activity, directs HIV-1 integration targeting sites. We also found that HIV-1 integrase proteins bind to the host genomic R-loops. These findings provide fundamental insights into the mechanisms of retroviral integration and the new strategies of antiretroviral therapy against HIV-1 latent infection.

2024-11-05 | GSE281027 | GEO

Human immunodeficiency virus-1 targets genomic R-loops of the host for integration [IS-seq]

2024-11-05 | GSE281026 | GEO

Human immunodeficiency virus-1 targets genomic R-loops of the host for integration [DRIPc]

2024-11-05 | GSE281025 | GEO

HIV-1 integration sites in the cells depleted for host facors SON, SRRM2; HIV-1 integration sites infected wild type HEK293T cells and HEK293T cells lacking CPSF6 but complemented for CPSF6 mutants. [CPSF6]

Project description:SON and SRRM2 were depleted in U2OS and HeLa cells and infected with HIV-1. Similarly HEK293T cells were infected with HIV-1 virus.

2025-04-01 | GSE264152 | GEO

Project description:SON and SRRM2 were depleted in U2OS and HeLa cells and infected with HIV-1. Similarly HEK293T cells were infected with HIV-1 virus.

2025-04-01 | GSE264150 | GEO

Higher-order chromatin structures of chromosomally-integrated HHV-6A predict Integration Sites

Project description:We used 4C sequencing technology for high-throughput profiling of HHV6A integration in both HEK293T cells and SMC cells. We identified genome-wide host-virus and virus-virus interactions profiles.

2020-12-09 | GSE162821 | GEO

HiC and H3K27ac HiChIP of clonal Jurkat T cells infected HIV-1 model NL4-3-D6-drEGFP

Project description:HIV-1 integration introduces ectopic transcription factor binding sites into host chromatin. We postulate that the integrated provirus serves as an ectopic enhancer that recruits additional transcriptional factors to the integration locus, increases chromatin accessibility, changes 3D chromatin interactions, and enhances both retroviral and host gene expression. We used 4 well-characterized HIV-1-infected cell line clones having unique integration sites and low to high levels of HIV-1 expression. Using single-cell DOGMA-seq, which captured the heterogeneity of HIV-1 expression and host chromatin accessibility, we found that HIV-1 transcription correlated with HIV-1 accessibility and host chromatin accessibility. HIV-1 integration increased local host chromatin accessibility within ~5–30 kb distance. CRISPRa and CRISPRi-mediated HIV-1 promoter activation and inhibition confirmed integration site-dependent HIV-1-driven changes of host chromatin accessibility. HIV-1 did not drive chromatin confirmation changes at the genomic level (by Hi-C) or the enhancer connectome (by H3K27Ac HiChIP). Using 4C-seq to interrogate HIV-1-chromatin interactions, we found that HIV-1 interacted with host chromatin ~100–300 kb from the integration site. By identifying chromatin regions having both increased transcription factor activity (by ATAC-seq) and HIV-1-chromtain interaction (by 4C-seq), we identified enrichment of ETS, RUNT, STAT, and ZNF transcription factor binding that may mediate HIV-1-host chromatin interactions. Our study found that HIV-1 promoter activity increased host chromatin accessibility, increased HIV-1-host chromatin interactions in an integration site dependent manner, within the existing chromatin boundaries without impacting broader host chromatin structure.

2023-05-01 | GSE230313 | GEO

Effects of dopamine on HIV latently-infected U1 macrophage cell line

Project description:U1 monocytic cell line was cloned from U937 cells that survived an infection with Human Immunodeficiency Virus HIV-1 and bear integration sites, serving as one of the most studied HIV latent models. Under the hypothesis that the hyperdopaminergic environment of the brain of substance users affects HIV-infected cells and latency, we tested the effects of Dopamine and two dopamine receptors that were identified as able to signal changes ininnate immune cells, DRD1 and DRD4.

2022-12-21 | GSE221531 | GEO

MVV vector integration in human cells

Project description:To test if LEDGF/p75 influences distribution of Maedi-visna virus (MVV) integration sites, we infected human HEK293T, LKO (PSIP1-null), and LHKO (PSIP1/HDGFL2-null) cells with MVV-derived vector. Genomic DNA was isolated from infected cells, and chromosomal junctions at integrated U5 vDNA ends were amplified using linker-mediated PCR, sequenced using Illumina technology and mapped to human genome.

2022-02-06 | GSE196040 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data